Primary abdominal malignant mesothelioma is a rare tumor. Over 70% of cases have a history of asbestos exposure. Presenting symptoms and signs include abdominal pain or bowel obstruction, increased abdominal girth, and small to moderate ascites. The chest radiograph reveals pulmonary asbestosis in over 50%. The ascitic fluid is hemorrhagic, with a low serum-ascites albumin gradient. Cytology is often negative. Abdominal CT or PET-CT may reveal sheet-like masses involving the mesentery and omentum. Diagnosis is made at laparotomy or laparoscopy. The prognosis is extremely poor, but long-term survivors have been described with a combination of surgical debulking of tumor followed by heated intraoperative intraperitoneal chemotherapy and early postoperative intraperitoneal chemotherapy. Postoperative radiotherapy or combination chemotherapy may be helpful. Multicystic and well-differentiated papillary mesotheliomas are associated with a long survival with surgical treatment alone.
PH. Update on the management of malignant peritoneal mesothelioma. Transl Lung Cancer Res. 2018 Oct;7(5):599–608.
et al. CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis. Radiol Med. 2016 Apr;121(4):253–60.
et al. CT differentiation of diffuse malignant peritoneal mesothelioma and peritoneal carcinomatosis. J Gastroenterol Hepatol. 2016 Apr;31(4):709–15.